نتائج البحث

LiO t Bu-Promoted Intramolecular 1,3-Dipolar Cycloaddition of the 2′-Alkynyl-biaryl-2-aldehyde N -Tosylhydrazones Approach to 3-Substituted 1 H -Dibenzo[ e , g ]indazoles.

• Authors : Lv, Jiaying¹ (AUTHOR) ; Hua, Ruimao^1,2 (AUTHOR)

• Source: Molecules. Dec2023, Vol. 28 Issue 24, p8061. 15p.

تفاصيل العنوان

Straightforward and Efficient Protocol for the Synthesis of Pyrazolo [4,3- b ]pyridines and Indazoles.

• Authors : Nikol'skiy, Vladislav V.¹ (AUTHOR); Minyaev, Mikhail E.¹ (AUTHOR); Bastrakov, Maxim A.¹ (AUTHOR)

• Source: International Journal of Molecular Sciences. Jan2023, Vol. 24 Issue 2, p1758. 16p.

تفاصيل العنوان

Antimicrobial Evaluation of New Pyrazoles, Indazoles and Pyrazolines Prepared in Continuous Flow Mode.

• Authors : Burke, Adam¹ (AUTHOR); Di Filippo, Mara¹ (AUTHOR); Spiccio, Silvia¹ (AUTHOR)

• Source: International Journal of Molecular Sciences. Mar2023, Vol. 24 Issue 6, p5319. 12p.

تفاصيل العنوان

Indazol-Pyrimidine Hybrids: Design, Synthesis, and Antiproliferative Activity Against Human Cancer Cell Lines.

• Authors : Al-Tuwaijri HM; Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.; El-Rashedy AA

Subjects: Pyrimidines*/Pyrimidines*/Pyrimidines*/chemistry ; Pyrimidines*/Pyrimidines*/Pyrimidines*/pharmacology ; Pyrimidines*/Pyrimidines*/Pyrimidines*/chemical synthesis

• Source: Molecules (Basel, Switzerland) [Molecules] 2025 Sep 17; Vol. 30 (18). Date of Electronic Publication: 2025 Sep 17.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Dissociation Between Tumor Response and PTTM Progression During Entrectinib Therapy in NTRK Fusion-Positive Colon Cancer.

• Authors : Nagano H; Department of Surgery, Marunouchi Hospital, Matsumoto 390-8601, Nagano, Japan.; Ohyama S

Subjects: Indazoles*/Indazoles*/Indazoles*/therapeutic use ; Indazoles*/Indazoles*/Indazoles*/pharmacology ; Colonic Neoplasms*/Colonic Neoplasms*/Colonic Neoplasms*/drug therapy

• Source: Current oncology (Toronto, Ont.) [Curr Oncol] 2025 Sep 11; Vol. 32 (9). Date of Electronic Publication: 2025 Sep 11.Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet

تفاصيل العنوان

Indazole Derivatives Against Murine Cutaneous Leishmaniasis.

• Authors : Mollineda-Diogo, Niurka¹ (AUTHOR); Pérez-Castillo, Yunierkis² (AUTHOR) ; Sifontes-Rodríguez, Sergio³ (AUTHOR)

• Source: Pharmaceuticals (14248247). Aug2025, Vol. 18 Issue 8, p1107. 13p.

تفاصيل العنوان

Synthesis of CF 3 -Indazoles via Rh(III)-Catalyzed C-H [4+1] Annulation of Azobenzenes with CF 3 -Imidoyl Sulfoxonium Ylides.

• Authors : Shang, Yilong¹ (AUTHOR); Li, Chen¹ (AUTHOR); Wang, Guiqiu¹ (AUTHOR)

• Source: Molecules. Jan2025, Vol. 30 Issue 1, p183. 14p.

تفاصيل العنوان

Assessment of Abuse Potential of Three Indazole-Carboxamide Synthetic Cannabinoids 5F-ADB, MDMB-4en-PINACA and ADB-4en-PINACA.

• Authors : Qiao Y; School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China.; Office of China National Narcotics Control Commission, China Pharmaceutical University Joint Laboratory on Key Technologies of Narcotics Control, Beijing 100193, China.

Subjects: Indazoles*/Indazoles*/Indazoles*/pharmacology ; Indazoles*/Indazoles*/Indazoles*/chemistry ; Indazoles*/Indazoles*/Indazoles*/adverse effects

• Source: International journal of molecular sciences [Int J Mol Sci] 2025 Jul 03; Vol. 26 (13). Date of Electronic Publication: 2025 Jul 03.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Trabectedin Induces Synthetic Lethality via the p53-Dependent Apoptotic Pathway in Ovarian Cancer Cells Without BRCA Mutations When Used in Combination with Niraparib.

• Authors : Kang B; Department of Chemistry, College of Natural Science, Kyungpook National University, Daegu 41944, Republic of Korea.; Lee SJ

Subjects: Apoptosis*/Apoptosis*/Apoptosis*/drug effects ; Tumor Suppressor Protein p53*/Tumor Suppressor Protein p53*/Tumor Suppressor Protein p53*/metabolism ; Tumor Suppressor Protein p53*/Tumor Suppressor Protein p53*/Tumor Suppressor Protein p53*/genetics

• Source: International journal of molecular sciences [Int J Mol Sci] 2025 Mar 24; Vol. 26 (7). Date of Electronic Publication: 2025 Mar 24.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Synthesis and Characterization of Novel Indazole–Sulfonamide Compounds with Potential MAPK1 Inhibitory Activity for Cancer Treatment.

• Authors : Saghdani, Nassima¹ (AUTHOR) ; Chihab, Abdelali¹ (AUTHOR); El Brahmi, Nabil¹ (AUTHOR)

• Source: Molbank. Sep2024, Vol. 2024 Issue 3, pM1858. 11p.

تفاصيل العنوان